These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11820525)

  • 1. Fibrosing skin condition among patients with renal disease--United States and Europe, 1997-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jan; 51(2):25-6. PubMed ID: 11820525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the Centers for Disease Control and Prevention. Fibrosing skin condition among patients with renal disease--United States and Europe, 1997-2002.
    JAMA; 2002 Feb; 287(7):838. PubMed ID: 11862962
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature.
    Introcaso CE; Hivnor C; Cowper S; Werth VP
    Int J Dermatol; 2007 May; 46(5):447-52. PubMed ID: 17472669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrogenic fibrosing dermopathy].
    Engelen JW; Kooistra MP; Canninga-van Dijk MR; Toonstra J; Sigurdsson V
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2435-8. PubMed ID: 14694555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic fibrosing dermopathy: a series in a non-Western population.
    Panda S; Bandyopadhyay D; Tarafder A
    J Am Acad Dermatol; 2006 Jan; 54(1):155-9. PubMed ID: 16384776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):137-41. PubMed ID: 17318112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate?
    Satter EK; Metcalf JS; Maize JC
    J Cutan Pathol; 2006 Nov; 33(11):756-9. PubMed ID: 17083697
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
    Kim RH; Ma L; Hayat SQ; Ahmed MM
    J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).
    Mackay-Wiggan JM; Cohen DJ; Hardy MA; Knobler EH; Grossman ME
    J Am Acad Dermatol; 2003 Jan; 48(1):55-60. PubMed ID: 12522371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.
    Daram SR; Cortese CM; Bastani B
    Am J Kidney Dis; 2005 Oct; 46(4):754-9. PubMed ID: 16183432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases.
    Streams BN; Liu V; Liégeois N; Moschella SM
    J Am Acad Dermatol; 2003 Jan; 48(1):42-7. PubMed ID: 12522369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.
    Jiménez SA; Artlett CM; Sandorfi N; Derk C; Latinis K; Sawaya H; Haddad R; Shanahan JC
    Arthritis Rheum; 2004 Aug; 50(8):2660-6. PubMed ID: 15334482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis.
    Baron PW; Cantos K; Hillebrand DJ; Hu KQ; Ojogho ON; Nehlsen-Cannarella S; Concepcion W
    Am J Dermatopathol; 2003 Jun; 25(3):204-9. PubMed ID: 12775982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrogenic fibrosing dermopathy.
    Firoz BF; Hunzeker CM; Soldano AC; Franks AG
    Dermatol Online J; 2008 May; 14(5):11. PubMed ID: 18627747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic fibrosing dermopathy: first Colombian case.
    Aluma MS; Restrepo R; Gaviria M
    Dermatol Online J; 2007 Jul; 13(3):24. PubMed ID: 18328218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Galan A; Cowper SE; Bucala R
    Curr Opin Rheumatol; 2006 Nov; 18(6):614-7. PubMed ID: 17053507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic fibrosing dermopathy: report of two cases.
    Aires NB; Sotto MN; Nico MM
    Acta Derm Venereol; 2007; 87(6):521-4. PubMed ID: 17989891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.
    Kucher C; Steere J; Elenitsas R; Siegel DL; Xu X
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S31-4. PubMed ID: 16427988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis.
    Gilliet M; Cozzio A; Burg G; Nestle FO
    Br J Dermatol; 2005 Mar; 152(3):531-6. PubMed ID: 15787823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.